Case Study:
GENENTECH AND NOVARTIS
Helping Achieve FDA Approval Through Superior Translations
Genentech and Novartis had invested millions of dollars into the development of Xolair. However, in order to submit the treatment to the FDA for approval, over 1,000 pages of documentation would need to be translated from French to English.
Click here to read more about this case study. |
